Evidence map›Paper›PMID 41736732›Full record

ArticleERJ open research2026

High

Kensuke Fukuda, Hirotaka Matsuzaki, Yukihiro Nomura, Takuya Kawahara, Takahiro Nakao, Toshihiro Yamaguchi, Shouhei Hanaoka, Akira Saito, Nobutake Yamamichi, Hidenori Kage and 1 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Kensuke FukudaDepartment of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0605-6681
Hirotaka MatsuzakiDepartment of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-8688-3005
Yukihiro NomuraCentre for Frontier Medical Engineering, Chiba University, Chiba, Japan.
Takuya KawaharaClinical Research Promotion Centre, The University of Tokyo Hospital, Tokyo, Japan.
Takahiro NakaoDepartment of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Toshihiro YamaguchiCentre for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Shouhei HanaokaDepartment of Radiology, The University of Tokyo Hospital, Tokyo, Japan.
Akira SaitoDepartment of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Nobutake YamamichiCentre for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Hidenori KageDepartment of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Takeharu YoshikawaDepartment of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pulmonary emphysema on computed tomography (CT) is a risk factor for all-cause mortality in individuals with and without airflow limitation. The aim of this study was to assess whether Methods: This single-centre retrospective observational study included participants who repeatedly underwent intensive cancer screening with unenhanced chest CT and semiquantitative Results: We evaluated 2112 participants (1502 male; mean±sd age 59±10 years; 395 currently smoking, 820 previously smoked; 1958 no emphysema, 152 mild emphysema, two moderate emphysema on visual CT inspection). The median follow-up duration was 1470 (interquartile range 1330-1705) days. Higher cSUV Conclusion: Semiquantitative FDG uptake was independently associated with longitudinal emphysema progression in both of the participants who currently and previously smoked. Semiquantitative PET/CT may provide useful information for early intervention in participants at high risk for emphysema progression.

Identifiers

PMID41736732
PMCPMC12926819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.